Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Carcinoma, Hepatocellular 71Pancreatic Neoplasms 69Colorectal Neoplasms 26Liver Neoplasms 20Neoplasm Metastasis 9Lung Neoplasms 8Melanoma 7Cholangiocarcinoma 6Sarcoma 5Neoplasms 5Colonic Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Gastrointestinal Neoplasms 4Esophageal Neoplasms 4Carcinoma, Renal Cell 4Brain Neoplasms 4Klatskin Tumor 3Urinary Bladder Neoplasms 2Unresectable Locally Recurrent Rectal Cancer 2Thyroid Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Locally Advanced Pancreatic Cancer 2Carcinoma, Non-Small-Cell Lung 2Bile Duct Neoplasms 2Adrenal Gland Neoplasms 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Spinal Cord Compression 1

Interventions

lutetium Lu 177 dotatate 8lanreotide 4copper dotatate CU-64 4Octreotide 4177Lu-octreotide, DOTA(0)-Tyr(3)- 4pasireotide 3Magnetic Resonance Spectroscopy 3Lutetium-177 3Lutetium 3gallium Ga 68 dotatate 2amino-acid, glucose, and electrolyte solution 2Temozolomide 2Nivolumab 2Irinotecan 2Ga(III)-DOTATOC 2Everolimus 2Etoposide 2Carboplatin 2zimberelimab 1regorafenib 1pembrolizumab 1irinotecan sucrosofate 1folfirinox 1famitinib 1cabozantinib 1arginyllysine 1abemaciclib 1X-Rays 1Sunitinib 1Somatostatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastro-enteropancreatic neuroendocrine tumor × Radiosurgery × Gastrointestinal × Clear all
NCT07150546 2026-03-02

Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.

Emory University

Phase 1 Recruiting
15 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡